#adbry

Collection of adbry news, found 1 news.

LEO Pharma announces FDA approval of Adbry™ (tralokinumab) as the first and only treatment specifically targeting IL-13 for adults with moderate-to-severe atopic dermatitis

LEO Pharma announces FDA approval of Adbry™ (tralokinumab) as the first and only treatment specifically targeting IL-13 for adults with moderate-to-severe atopic dermatitis

  • 28th December 2021

LEO Pharma A/S, a global leader in medical dermatology, announced today that the U.S. Food and Drug Administration ...